140 related articles for article (PubMed ID: 26270118)
41. Tumor necrosis factor α -308 G>A polymorphisms and cervical cancer risk: a meta-analysis.
Ding B; Fu S; Wang M; Yue C; Wang W; Zhou D; Zhang Z; Han S
Int J Gynecol Cancer; 2012 Feb; 22(2):213-9. PubMed ID: 22146770
[TBL] [Abstract][Full Text] [Related]
42. Association analysis between the TLR9 gene polymorphism rs352140 and type 1 diabetes.
Wang Y; Xia Y; Chen Y; Xu L; Sun X; Li J; Huang G; Li X; Xie Z; Zhou Z
Front Endocrinol (Lausanne); 2023; 14():1030736. PubMed ID: 37139337
[TBL] [Abstract][Full Text] [Related]
43. Toll-Like Receptor (TLR)-9 rs352140 Polymorphism is an Immunopathology Protective Factor in Parkinson's Disease in the Northern Iranian Population.
Miri NS; Saadat P; Azadmehr A; Oladnabi M; Daraei A
Iran J Immunol; 2020 Dec; 17(4):313-323. PubMed ID: 33382388
[TBL] [Abstract][Full Text] [Related]
44. Association of TLR4 (D299G, T399I), TLR9 -1486T>C, TIRAP S180L and TNF-α promoter (-1031, -863, -857) polymorphisms with risk for systemic lupus erythematosus among South Indians.
Rupasree Y; Naushad SM; Rajasekhar L; Uma A; Kutala VK
Lupus; 2015 Jan; 24(1):50-7. PubMed ID: 25182168
[TBL] [Abstract][Full Text] [Related]
45. Association of single nucleotide polymorphisms in tumor necrosis factor-alpha with cervical cancer susceptibility.
Jin Y
Cell Biochem Biophys; 2015 Jan; 71(1):77-84. PubMed ID: 25069725
[TBL] [Abstract][Full Text] [Related]
46. Association of toll-like receptor polymorphisms with acquisition of HIV infection and clinical findings: A protocol for systematic review and meta-analysis.
Shi H; He H; Sun C; Fu J; Ghosh D; Deng C; Sheng Y
Medicine (Baltimore); 2020 Dec; 99(52):e23663. PubMed ID: 33350746
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in the toll-like receptor 9 gene associated with sepsis and multiple organ dysfunction after major blunt trauma.
Chen KH; Zeng L; Gu W; Zhou J; Du DY; Jiang JX
Br J Surg; 2011 Sep; 98(9):1252-9. PubMed ID: 21633947
[TBL] [Abstract][Full Text] [Related]
48. Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibility.
Chauhan A; Pandey N; Desai A; Raithatha N; Patel P; Choxi Y; Kapadia R; Khandelwal R; Jain N
PLoS One; 2019; 14(7):e0220330. PubMed ID: 31365550
[TBL] [Abstract][Full Text] [Related]
49. Association of TLR9 polymorphisms with sporadic Parkinson's disease in Chinese Han population.
Zhu K; Teng J; Zhao J; Liu H; Xie A
Int J Neurosci; 2016; 126(7):612-6. PubMed ID: 26000920
[TBL] [Abstract][Full Text] [Related]
50. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
51. The
Jabłońska A; Jabłonowska E; Studzińska M; Kamerys J; Paradowska E
Cells; 2021 Sep; 10(9):. PubMed ID: 34572011
[TBL] [Abstract][Full Text] [Related]
52. Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study.
Omar AH; Yasunami M; Yamazaki A; Shibata H; Ofori MF; Akanmori BD; Shuaibu MN; Kikuchi M; Hirayama K
Malar J; 2012 May; 11():168. PubMed ID: 22594374
[TBL] [Abstract][Full Text] [Related]
53. Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.
Xia W; Xu Y; Mao Q; Dong G; Shi R; Wang J; Zheng Y; Xu L; Jiang F
Med Oncol; 2015 Feb; 32(2):442. PubMed ID: 25603950
[TBL] [Abstract][Full Text] [Related]
54. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
55. Association of Polymorphisms in Innate Immunity Genes TLR9 and DEFB1 with Human Longevity.
Gankovskaya LV; Svitich OA; Artem'eva OV; Miroshnichenkova AM; Rusanova KV
Bull Exp Biol Med; 2015 May; 159(1):77-80. PubMed ID: 26028230
[TBL] [Abstract][Full Text] [Related]
56. C-reactive Protein -717A>G and -286C>T>A Gene Polymorphism and Ischemic Stroke.
Liu Y; Geng PL; Yan FQ; Chen T; Wang W; Tang XD; Zheng JC; Wu WP; Wang ZF
Chin Med J (Engl); 2015 Jun; 128(12):1666-70. PubMed ID: 26063371
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms in TLR9 but not in TLR5 increase the risk for duodenal ulcer and alter cytokine expression in the gastric mucosa.
Trejo-de la O A; Torres J; Sánchez-Zauco N; Pérez-Rodríguez M; Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Maldonado-Bernal C
Innate Immun; 2015 Oct; 21(7):706-13. PubMed ID: 25995217
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms and haplotypes of TLR-4/9 associated with bacterial infection, gingival inflammation/recession and oral cancer.
Jha A; Nath N; Kumari A; Kumari N; Panda AK; Mishra R
Pathol Res Pract; 2023 Jan; 241():154284. PubMed ID: 36563560
[TBL] [Abstract][Full Text] [Related]
59. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever.
Engin A; Arslan S; Kizildag S; Oztürk H; Elaldi N; Dökmetas I; Bakir M
Microbes Infect; 2010 Nov; 12(12-13):1071-8. PubMed ID: 20674764
[TBL] [Abstract][Full Text] [Related]
60. A meta-analysis of TLR4 and TLR9 SNPs implicated in severe malaria.
Dhangadamajhi G; Kar A; Rout R; Dhangadamajhi P
Rev Soc Bras Med Trop; 2017; 50(2):153-160. PubMed ID: 28562749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
